why choose us

First received: November 02, 2022

Clinical Trial: Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial

Study Status: Completed

Recruit Status: RECRUITING

Condition: Diabetic Macular Edema

Study Type: INTERVENTIONAL


Official Title: Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial

Brief Summary: This study will assess a pragmatic, treat and extend regimen of faricimab against the standard of a fixed dosing regimen.

Read more